These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 12618684

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis.
    Grunwald MR, Hofmann LV.
    J Vasc Interv Radiol; 2004 Apr; 15(4):347-52. PubMed ID: 15064337
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion.
    Shortell CK, Queiroz R, Johansson M, Waldman D, Illig KA, Ouriel K, Green RM.
    J Vasc Surg; 2001 Nov; 34(5):854-9. PubMed ID: 11700486
    [Abstract] [Full Text] [Related]

  • 4. Clinical and economic outcomes in thrombolytic treatment of peripheral arterial occlusive disease and deep venous thrombosis.
    Ouriel K, Kaul AF, Leonard MC.
    J Vasc Surg; 2004 Nov; 40(5):971-7. PubMed ID: 15557913
    [Abstract] [Full Text] [Related]

  • 5. Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients.
    Kim HS, Preece SR, Black JH, Pham LD, Streiff MB.
    J Vasc Surg; 2008 Feb; 47(2):388-94. PubMed ID: 18241762
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis.
    Agle SC, McNally MM, Powell CS, Bogey WM, Parker FM, Stoner MC.
    Ann Vasc Surg; 2010 Jul; 24(5):609-14. PubMed ID: 20413257
    [Abstract] [Full Text] [Related]

  • 11. Catheter-directed thrombolysis of proximal lower extremity deep vein thrombosis: a prospective trial with venographic and clinical follow-up.
    Manninen H, Juutilainen A, Kaukanen E, Lehto S.
    Eur J Radiol; 2012 Jun; 81(6):1197-202. PubMed ID: 21498014
    [Abstract] [Full Text] [Related]

  • 12. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N, Gits CC, Ehrenwald E, Cragg AH.
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adjunctive percutaneous mechanical thrombectomy for lower-extremity deep vein thrombosis: clinical and economic outcomes.
    Kim HS, Patra A, Paxton BE, Khan J, Streiff MB.
    J Vasc Interv Radiol; 2006 Jul; 17(7):1099-104. PubMed ID: 16868161
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Catheter directed thrombolysis for early left lower extremity deep venous thrombosis without vena cava filters protection].
    Xiao L, Gong KM, Wang KH, Lü YJ, Chen ZS, Ouyang YM, Ling P, Long YX, Li LH.
    Zhonghua Wai Ke Za Zhi; 2012 Jan 01; 50(1):15-8. PubMed ID: 22490283
    [Abstract] [Full Text] [Related]

  • 18. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis.
    Ouriel K, Gray B, Clair DG, Olin J.
    J Vasc Interv Radiol; 2000 Mar 01; 11(3):295-8. PubMed ID: 10735422
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.